4//SEC Filing
Matkovits Theresa 4
Accession 0001493152-20-000118
CIK 0001582554other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:05 PM ET
Size
16.0 KB
Accession
0001493152-20-000118
Insider Transaction Report
Form 4
Matkovits Theresa
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2020-01-01+350,000→ 350,000 totalExercise: $2.27Exp: 2030-01-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001745393
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:05 PM ET
- Size
- 16.0 KB